Department of Ophthalmology, Maisonneuve-Rosemont Hospital Research Center, University of Montréal, Montréal, QC H1T 2H2, Canada.
Departments of Pediatrics, Ophthalmology and Pharmacology, Centre Hospitalier Universitaire Sainte-Justine Research Center, Montréal, QC H1T 2H2, Canada.
Int J Mol Sci. 2023 Aug 24;24(17):13185. doi: 10.3390/ijms241713185.
Endothelial Progenitor Cells (EPCs) can actively participate in revascularization in oxygen-induced retinopathy (OIR). Yet the mechanisms responsible for their dysfunction is unclear. Nogo-A, whose function is traditionally related to the inhibition of neurite function in the central nervous system, has recently been documented to display anti-angiogenic pro-repellent properties. Based on the significant impact of EPCs in retinal vascularization, we surmised that Nogo-A affects EPC function, and proceeded to investigate the role of Nogo-A on EPC function in OIR. The expression of Nogo-A and its specific receptor NgR1 was significantly increased in isolated EPCs exposed to hyperoxia, as well as in EPCs isolated from rats subjected to OIR compared with respective controls (EPCs exposed to normoxia). EPCs exposed to hyperoxia displayed reduced migratory and tubulogenic activity, associated with the suppressed expression of prominent EPC-recruitment factors SDF-1/CXCR4. The inhibition of Nogo-A (using a Nogo-66 neutralizing antagonist peptide) or siRNA-NGR1 in hyperoxia-exposed EPCs restored SDF-1/CXCR4 expression and, in turn, rescued the curtailed neovascular functions of EPCs in hyperoxia. The in vivo intraperitoneal injection of engineered EPCs (Nogo-A-inhibited or NgR1-suppressed) in OIR rats at P5 (prior to exposure to hyperoxia) prevented retinal and choroidal vaso-obliteration upon localization adjacent to vasculature; coherently, the inhibition of Nogo-A/NgR1 in EPCs enhanced the expression of key angiogenic factors VEGF, SDF-1, PDGF, and EPO in retina; CXCR4 knock-down abrogated suppressed NgR1 pro-angiogenic effects. The findings revealed that hyperoxia-induced EPC malfunction is mediated to a significant extent by Nogo-A/NgR1 signaling via CXCR4 suppression; the inhibition of Nogo-A in EPCs restores specific angiogenic growth factors in retina and the ensuing vascularization of the retina in an OIR model.
内皮祖细胞 (EPCs) 可积极参与氧诱导的视网膜病变 (OIR) 中的再血管化。然而,导致其功能障碍的机制尚不清楚。Nogo-A 的功能传统上与中枢神经系统中神经突起功能的抑制有关,最近有文献报道其具有抗血管生成的促排斥特性。基于 EPCs 在视网膜血管生成中的重要作用,我们推测 Nogo-A 影响 EPC 功能,并进一步研究了 Nogo-A 对 OIR 中 EPC 功能的作用。与相应的对照组(暴露于常氧的 EPCs)相比,在暴露于高氧的分离的 EPCs 以及从 OIR 大鼠中分离的 EPCs 中,Nogo-A 及其特异性受体 NgR1 的表达显著增加。暴露于高氧的 EPCs 的迁移和管状形成活性降低,与主要 EPC 募集因子 SDF-1/CXCR4 的表达受抑制有关。在高氧暴露的 EPCs 中抑制 Nogo-A(使用 Nogo-66 中和拮抗剂肽)或 siRNA-NgR1 恢复了 SDF-1/CXCR4 的表达,并进而挽救了高氧暴露的 EPCs 中受损的新生血管功能。在 P5 时(在暴露于高氧之前),将工程化的 EPCs(抑制 Nogo-A 或抑制 NgR1)腹膜内注射到 OIR 大鼠中,可防止视网膜和脉络膜血管阻塞在血管附近定位时发生;一致地,EPCs 中 Nogo-A/NgR1 的抑制增强了血管生成因子 VEGF、SDF-1、PDGF 和 EPO 在视网膜中的表达;CXCR4 敲低消除了受抑制的 NgR1 促血管生成作用。研究结果表明,高氧诱导的 EPC 功能障碍在很大程度上是由 Nogo-A/NgR1 信号通过 CXCR4 抑制介导的;EPCs 中 Nogo-A 的抑制可恢复特定的血管生成生长因子,并在 OIR 模型中促进视网膜的血管化。